Ameritas Investment Partners’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Ameritas Investment Partners’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,155	Closed	-$4K	–	3329
2021 Q1	$4K	Hold	1,155	–	–	﹤0.01%	3048
2020 Q4	$22K	Hold	1,155	–	–	﹤0.01%	2434
2020 Q3	$16K	Hold	1,155	–	–	﹤0.01%	2509
2020 Q2	$49K	Buy	1,155 +180	+18%	+$5.83K	﹤0.01%	1844
2020 Q1	$27K	Hold	975	–	–	﹤0.01%	2019
2019 Q4	$32K	Hold	975	–	–	﹤0.01%	2168
2019 Q3	$25K	Buy	975 +405	+71%	+$13.6K	﹤0.01%	2281
2019 Q2	$21K	Hold	570	–	–	﹤0.01%	2425
2019 Q1	$13K	Hold	570	–	–	﹤0.01%	2616
2018 Q4	$8K	Hold	570	–	–	﹤0.01%	2760
2018 Q3	$11K	Hold	570	–	–	﹤0.01%	2813
2018 Q2	$13K	Hold	570	–	–	﹤0.01%	2758
2018 Q1	$12K	Buy	+570	New	+$13.4K	﹤0.01%	2671

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ameritas Investment Partners's ODT Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 1,155 shares — an estimated $4K sold.

Ameritas Investment Partners first reported a position in ODT in Q1 2018 and held it in 13 quarters. The position peaked at $49K in Q2 2020. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

Ameritas Investment Partners reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 1,155 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $4K.
Ameritas Investment Partners first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 13 quarters.
Ameritas Investment Partners's Odonate Therapeutics, Inc. Common Stock position peaked at $49K in Q2 2020.
69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.